GlassScriptPhysician profile
Justin Somerville
NPI 1023016672
$1,670.23
in general payments reported to CMS, 2019-2025
15 companies · $16.59 in 2025
The $16.59 reported for 2025 was less than what a typical Colon & Rectal Surgery provider received nationally (typical 2025 total: $317).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $563 · 2021: $938 · 2022: $104 · 2023: $13.29 · 2024: $35.34 · 2025: $16.59.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $65.22.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $65.22 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Stryker Corporation | $668.11 | 2021 | |
| Davol INC. | $358.34 | 2019-2021 | |
| Intuitive Surgical, INC. | $120.61 | 2019 | |
| Acell, INC. | $105.69 | 2019 | |
| Axonics, INC. | $104.16 | 2022 | |
| Applied Medical Resources Corporation | $66.98 | 2019 | |
| Smith+Nephew, INC. | $60.17 | 2019 | |
| Ferring Pharmaceuticals INC. | $38.91 | 2019 | |
| Exact Sciences Corporation | $35.34 | 2024 | Cologuard Collection Kit |
| Conmed Corporation | $27.72 | 2021 | |
| Shire North American Group INC | $23.92 | 2019 | |
| Thd America, INC. | $17.11 | 2021 | |
| Reprise Biomedical, INC. | $16.59 | 2025 | Miro3d |
| Janssen Pharmaceuticals, INC | $13.29 | 2023 | Xarelto |
| Trevena, INC. | $13.29 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Justin Somerville listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.